Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
767.76
+10.22 (1.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eli Lilly Operating Expense Breakdown
History
| Date | Acquired In-Process Research and Development | Research and Development | Marketing, Selling, and Administrative | Impairment, Restructuring, and Other |
|---|---|---|---|---|
| Sep 30, 2024 | 3.71B | 10.53B | 8.09B | 523.37M |
| Jun 30, 2024 | 3.86B | 10.21B | 7.80B | 441.77M |
| Mar 31, 2024 | 3.81B | 9.85B | 7.61B | - |
| Dec 31, 2023 | 3.80B | 9.31B | 7.40B | 6.77M |
| Sep 30, 2023 | 3.42B | 8.75B | 7.12B | - |
| Jun 30, 2023 | 504.60M | 8.14B | 6.93B | - |
| Mar 31, 2023 | 847.90M | 7.57B | 6.63B | - |
| Dec 31, 2022 | 908.50M | 7.19B | 6.44B | 244.60M |
| Sep 30, 2022 | 1.11B | 7.15B | 6.39B | 311.00M |
| Jun 30, 2022 | 1.22B | 7.06B | 6.35B | - |
| Mar 31, 2022 | 823.70M | 6.95B | 6.41B | - |
| Dec 31, 2021 | 970.10M | 7.03B | 6.43B | 316.10M |
| Sep 30, 2021 | 898.70M | 6.90B | 6.39B | - |
| Jun 30, 2021 | 721.10M | 6.66B | 6.38B | - |
| Mar 31, 2021 | 920.10M | 6.38B | 6.15B | 282.90M |
| Dec 31, 2020 | 660.40M | 6.09B | 6.12B | 131.20M |
| Sep 30, 2020 | - | 5.83B | 6.27B | 313.00M |
| Jun 30, 2020 | 371.80M | 5.74B | 6.11B | - |
| Mar 31, 2020 | 155.00M | 5.76B | 6.25B | 211.60M |
| Dec 31, 2019 | - | 5.60B | 6.21B | 575.60M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.